drugset / Trial / NCT00426673

An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.

NCT00426673

Phase 1 Completed 15 enrolled UCB Pharma
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The primary objective of this Phase I study in 15 adult subjects suffering from epilepsy and chronically treated with phenytoin monotherapy is to evaluate the effect of steady-state ucb 34714 administration on the steady-state plasma levels of phenytoin.

Timeline

Start
2005-04
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Brivaracetam Small molecule

Indications